halofenate , a serum lipid-lowering agent which inhibits binding of thyroid hormone to thyroxine-binding globulin ( tbg ) , was administered daily for 14 days to 8 hypothyroid subjects with elevated tsh concentrations as a result of incomplete thyroxine ( t4 ) therapy .
C0020676
hypothyroid
C0040165
thyroxine